Evan Zimmerman is a venture capital investor at Jovono who started as a hands-on patent operator before becoming an investor, giving him deep practical IP experience that he uses as a core value-creation tool for portfolio companies rather than just legal protection. Unlike most VCs, he simultaneously runs his own Y Combinator-backed startup (Edge, an AI assistant for patent practitioners) while actively investing, and he focuses on small but fast-growing markets rather than chasing already-large opportunities.

• Deep interest in the intersection of philosophy and artificial intelligence. He draws intellectual connections between historical figures and modern large language models, such as comparing Rousseau's theories on the link between language and reasoning to how current AI models function.
• A focus on thoughtful product design and specific user experience details. He critiques over-engineering, noting that the Apple Car should have prioritized great design over space-age features, and expresses a wish for richer data in apps, like wanting Spotify to include liner notes and credits for classical musicians.
• Advocacy for open API access and the utility of AI agents in business workflows. He argues that software platforms should not block agents from accessing data because that data belongs to the user, and he provides specific product feedback to tools like Granola, suggesting they need better automatic CRM integrations.
• Enjoys discussing the lighter, personal side of parenting. He frequently shares a thread of selfish reasons to have children, offering humorous examples like the free workout you get from carrying them around and the nostalgia of watching them open holiday presents.
• Concerns regarding antitrust regulations and their potential negative impact on startup exits. He supports the idea that blocking mergers and acquisitions discourages investors and entrepreneurs, citing the blocked iRobot deal as an example of policy chilling the willingness to build great companies.
• Observations on the speed of innovation and regulation in biotechnology. He highlights that the competitive advantage of other markets, particularly China, is often speed rather than just cost, noting that regulatory approvals there can happen much faster than the year-long waits common domestically.
• Practical perspectives on autonomous driving technology as a user. He predicts that companies like Tesla will eventually need to adopt LiDAR technology for safety redundancy, arguing that despite the current focus on vision-only systems, having backup sensors is a logical step for full self-driving capabilities.